Related Experiment Video
Updated: Jul 19, 2025

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study
Teba González-Ferrero1,2,3, Marco Bergonti4,5,6, José Nicolás López-Canoa3,7
1Cardiovascular Area and Coronary Unit, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Insights
Arrhythmia-induced cardiomyopathy (AiCM) affects 17.56% of atrial fibrillation (AF) patients undergoing ablation. Persistent AF and chronic kidney disease predict AiCM, which improves after ablation with similar recurrence rates to non-AiCM patients.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Research
Background:
- Atrial fibrillation (AF) can lead to arrhythmia-induced cardiomyopathy (AiCM).
- Catheter ablation (CA) is a treatment option for AF, but its effect on AiCM requires further investigation.
- Understanding predictors and outcomes of AiCM post-ablation is crucial for patient management.
Purpose of the Study:
- To investigate the clinical and biochemical characteristics of patients with AF undergoing CA who develop AiCM.
- To assess the long-term outcomes of CA in patients with and without AiCM.
- To identify predictors of AiCM development and recurrence after CA.
Main Methods:
- Prospective multicentre study of consecutive AF patients undergoing CA.
- AiCM defined by heart failure development with AF and ≥10% improvement in left ventricular ejection fraction 6 months post-ablation.
- Biomarker analysis (galectin-3, FABP4, sRAGE) in a subgroup of patients.
Main Results:
- 17.56% of 769 AF patients developed AiCM.
- Predictors of AiCM included persistent AF, male gender, left atrial volume, QRS width, smoking, and chronic kidney disease (CKD).
- Biomarkers (sRAGE, FABP4, galectin-3) did not predict AiCM or recurrence. AF recurrence rates were similar between AiCM and non-AiCM groups (30.83% vs. 27.77%).
Conclusions:
- AiCM development in AF patients undergoing ablation is associated with persistent AF and CKD.
- Biomarker analysis did not predict AiCM or recurrence.
- Patients with AiCM benefit from CA, showing improved left ventricular ejection fraction and comparable AF recurrence rates to those without AiCM.
Aims:
This study aims to investigate the clinical and biochemical characteristics of patients with atrial fibrillation (AF) referred for ablation who develop arrhythmia-induced cardiomyopathy (AiCM) as well as their long-term outcomes after catheter ablation (CA).
Methods And Results:
A prospective multicentre study was conducted on consecutive AF patients who underwent CA. AiCM was defined as the development of heart failure in the presence of AF and an improvement of left ventricular fraction by at least 10% at 6 months after ablation. A subgroup of patients underwent peripheral and left atrial blood samples [galectin-3, fatty acid-binding protein 4 (FABP4), and soluble receptor for advanced glycation end products (sRAGE)] at the time of the procedure. Of the 769 patients who underwent AF ablation, 135 (17.56%) met the criteria for AiCM. Independent predictors of AiCM included persistent AF, male gender, left atrial volume, QRS width, active smoking, and chronic kidney disease (CKD). Biomarker analysis revealed that sRAGE, FABP4, and galectin-3 levels were not predictive of AiCM development nor did they differ between groups or predict recurrence. There were no differences in AF recurrence between patients with and without AiCM (30.83% vs. 27.77%; P = 0.392) during a median follow-up of 23.83 months (inter-quartile range 9-36).
Conclusions:
In the subset of patients referred for AF ablation, the development of AiCM was associated with persistent AF and CKD. Biomarker analysis was not different between groups nor predicted recurrence. Patients with AiCM benefited from ablation, with a significant improvement in left ventricular ejection fraction and similar AF recurrence rates to those without AiCM.
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

